Mepavlon en es it fr

Mepavlon Brand names, Mepavlon Analogs

Mepavlon Brand Names Mixture

  • No information avaliable

Mepavlon Chemical_Formula


Mepavlon RX_link

No information avaliable

Mepavlon fda sheet

Mepavlon msds (material safety sheet)

Mepavlon Synthesis Reference

No information avaliable

Mepavlon Molecular Weight

309.469 g/mol

Mepavlon Melting Point

< 25 oC

Mepavlon H2O Solubility

Soluble as HCl salt

Mepavlon State


Mepavlon LogP


Mepavlon Dosage Forms

Tablets (oral, 1 mg)

Mepavlon Indication

Used for the symptomatic treatment of parkinsonism.

Mepavlon Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Mepavlon Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Mepavlon side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Mepavlon Patient Information

Mepavlon Organisms Affected

Humans and other mammals